SAN DIEGO--(BUSINESS WIRE)--SynteractHCR, a full-service, international contract research organization (CRO), will be hosting limited-registration training classes for CDISC, a global, nonprofit organization that has established standards to support the acquisition, exchange, submission and archiving of clinical research data. The classes will be held Jan. 27-30 at SynteractHCR’s global headquarters in Carlsbad, Calif.
CDISC collaborates with CROs, including SynteractHCR, to develop uniform data standards for clinical trials. SynteractHCR has provided feedback and industry expertise to the organization throughout this process as well as assistance with creating uniform data sets that meet the needs of CROs. In turn, SynteractHCR uses its knowledge of regulatory requirements and standards to guide biopharma clients.
The training classes will be conducted by CDISC teachers and will cover all CDISC standards. The training is appropriate for data management and biostatistics professionals in biotech and pharma companies. A class list and registration dates are available on CDISC’s website. SynteractHCR will also make CDISC classes available Feb. 10-13 at its North Carolina office in Research Triangle Park.
“SynteractHCR is pleased to once again have the opportunity to participate in improving the quality, efficiency and cost effectiveness of clinical research processes through CDISC’s platform-independent data standards,” said Olivia Montaño, senior director, clinical data management at SynteractHCR. “We provide these training sessions to stay at the top of our industry in data management, which helps us direct our clients through the drug development process with accurate data collection from start to finish.”
SynteractHCR is also hosting a one-day implementation course on CDASH, which describes basic data collection fields common to all therapeutic areas and all types of clinical research. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website.
About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and Intelligent Clinical Development platform (ICD+), SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.